FealtySign in

LABCORP HOLDINGS INC.

(LH)

CIK 920148 · SEC filings only

Not yet gradedBuyback record
harness minimum not met
company entity
1 resolved promise

Not enough resolved promises to grade

1 of the 4 resolved buyback promises needed to publish a reliability grade. Here's what we're tracking — we never show a grade we can't back with receipts.

Resolved promises

Pro

Full say-do history

Free scorecards show the 12 most recent resolved buyback promises. See the complete multi-year record with Pro.

See Pro →

Open promises (3)

Open · buyback authorization

the authorization of a $2.5 billion share repurchase program

unresolved — no outcome on file$2.5000receipt (opens in a new tab)
Open · buyback authorization

the Board of Directors has approved an additional $1.00 billion for share repurchases

unresolved — no outcome on file$1.0000receipt (opens in a new tab)
Open · buyback authorization

Board of Directors approved an increase in share repurchase authorization by $1.0 billion to a total of $1.4 billion

next filing due$1.4000receipt (opens in a new tab)

Credibility timeline

PARTIAL · Oct 31, 2025
20252025
Timeline as a list
  • Oct 31, 2025PARTIALAnnounced a $1.0 billion accelerated share repurchase program
1 resolved buyback promise · resolver resolver-v3 · score score-v1. Every verdict links to its source filing. Full methodology →
B+Guidance record
grade
company entity
7 resolved promises

Sector median (Industrial Applications and Services): B+ across 28 graded companies

Resolved promises

Pro

Full say-do history

Free scorecards show the 12 most recent resolved guidance promises. See the complete multi-year record with Pro.

See Pro →

Guidance by basis

7 of 14 guidance figures that were graded or dropped for basis could not be graded on the same basis (50%). Guidance marked “not judged” is in neither number.

Guidance typeSaidGradedDroppedOther
Revenue · basis not stated217014
EPS · non-GAAPcannot be graded200713

Said counts every revenue and EPS guidance figure on record. Dropped counts figures whose period was reported but which have no comparable GAAP actual in SEC XBRL. Other covers open, superseded, withdrawn and otherwise unresolved figures. The coverage note below counts every figure shown but not graded, including figures whose period has not been reported, so it can be larger.

How the site-wide rate is measured

Compare across companies

Guidance shown, not graded (21)

We show what was said — with its source filing — but never score it. The line under each statement says why.

  1. eps guidance fy · Feb 17, 2026
    Adjusted EPS of $17.55 to $18.25
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  2. eps guidance fy · Feb 6, 2025
    Adjusted EPS of $15.60 to $16.40
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  3. eps guidance fy · Oct 24, 2024
    Adjusted EPS range of $14.30 to $14.70
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  4. eps guidance fy · Aug 1, 2024
    Adjusted EPS range of $14.30 to $14.90
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  5. eps guidance fy · Feb 15, 2024
    Adjusted EPS $13.56 $14.30 $15.40
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  6. eps guidance fy · Oct 26, 2023
    Adjusted EPS $16.66 $13.00 $14.00 $13.25 $13.75
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  7. eps guidance fy · Jul 27, 2023
    Adjusted EPS of $13.00 to $14.00
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  8. eps guidance fy · Apr 25, 2023
    Adjusted EPS narrowed to $16.25 to $17.75
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  9. eps guidance fy · Feb 16, 2023
    Adjusted EPS $19.94 $16.00 $18.00
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  10. revenue guidance fy · Oct 27, 2022
    Total Labcorp Enterprise (1)(2) $16.1
    Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
  11. eps guidance fy · Oct 27, 2022
    Adjusted EPS $28.52 $19.00 $21.25
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  12. eps guidance fy · Apr 28, 2022
    Adjusted EPS improved to $18.25 to $21.00
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  13. eps guidance fy · Feb 10, 2022
    Adjusted EPS $28.52 $17.25 $21.25
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  14. eps guidance fy · Oct 28, 2021
    Adjusted EPS raised to range of $26.00 to $28.00
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  15. eps guidance fy · Jul 29, 2021
    Adjusted EPS raised to range of $21.50 to $25.00
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  16. eps guidance fy · Apr 29, 2021
    Adjusted EPS raised to $20.00 to $24.00
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  17. eps guidance fy · Feb 11, 2021
    Adjusted EPS $ 23.94 $ 19.00 $ 23.00
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  18. eps guidance fy · Apr 29, 2020
    expects to deliver solid adjusted EPS
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  19. eps guidance fy · Feb 13, 2020
    Adjusted EPS of $11.75 to $12.15
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  20. eps guidance fy · Apr 30, 2019
    Adjusted EPS of $11.05 to $11.45
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  21. eps guidance fy · Oct 20, 2011
    Adjusted EPS Excluding Amortization of $6.28 to $6.33
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗

Open promises (1) · 11 superseded

Open · revenue guidance fy

Revenue of $14.61 billion to $14.79 billion

resolves in ~155 daysreceipt (opens in a new tab)
Superseded · revenue guidance fy

Revenue Total Labcorp Enterprise (1)(2) $ 13.98 (1.0%) 4.5%

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

Revenue range of 6.4% to 7.5%

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

Revenue Total Labcorp Enterprise (1)(2) $16.1 (6.5%) (1.5%)

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

Revenue raised to range of 6.5% to 9.0%

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

Total Labcorp Enterprise (1)(2) $11.9

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

Revenue raised to 2.0% to 6.5%

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

Revenue Total Labcorp Enterprise (1)(2) $14.9

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

Revenue Labcorp Enterprise (1)(2) $12.2

revised by a later guidance$12.2000receipt (opens in a new tab)
Superseded · revenue guidance fy

Total Labcorp Enterprise (1)(2) $16.1

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

Revenue Labcorp Enterprise (1)(2) $12.2

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

Total Labcorp Enterprise (1)(2) $14.9 1.0% 4.0% 1.5% 4.0%

revised by a later guidancereceipt (opens in a new tab)

Credibility timeline

IN LINE · Feb 24, 2012IN LINE · Feb 28, 2020WITHDRAWN · Apr 29, 2020WITHDRAWN · Apr 29, 2020ABOVE · Feb 25, 2022BELOW · Feb 28, 2023IN LINE · Feb 26, 2024IN LINE · Feb 25, 2025IN LINE · Feb 24, 2026
20122026
Timeline as a list
  • Feb 24, 2012IN LINEexpecting revenue growth of approximately 10.5% - 11.0%
  • Feb 28, 2020IN LINERevenue growth of 0.5% to 2.5% over 2018 revenue of $11.33 billion
  • Apr 29, 2020WITHDRAWNLabCorp withdraws 2020 guidance
  • Apr 29, 2020WITHDRAWNRevenue growth of 4.0% to 6.0% over 2019 revenue of $11.55 billion
  • Feb 25, 2022ABOVERevenue raised to range of 13.0% to 14.0%
  • Feb 28, 2023BELOWTotal Labcorp Enterprise (1)(2) $16.1
  • Feb 26, 2024IN LINETotal Labcorp Enterprise (1)(2) $11.86 1.5% 3.0% 1.9% 2.7%
  • Feb 25, 2025IN LINERevenue range of 6.6% to 7.3%
  • Feb 24, 2026IN LINERevenue of $13.88 billion to $14.05 billion
7 resolved guidance promises · 21 not graded (no comparable reported figure) · resolver resolver-v5 · score score-v1. Every verdict links to its source filing. Full methodology →